Depression prevalence among diabetic patients and comparison of demographics and complications




Diabetes Mellitus, Depression, Beck Depression Inventory


Background/Aim: Living with diabetes brings psychological difficulties for many patients and puts them in a depressed state. This reduces follow-up and treatment compliance and increases anxiety in terms of complications. Incompliance of follow-up and treatment can increase macro and micro complications in patients in a vicious circle. In this respect, clinicians should be careful during the follow-up and treatment of the patients. In this study, our aim was to determine the depression rate among diabetic patients and its relationship with demographic findings and complications. Methods: Patients who are followed up regularly at our hospital’s diabetes clinic between July and August 2019 were included and a case-control study was planned. BDI questions were answered by patients under supervision after obtaining patient consent. Patients with BDI >16 were considered depressed. Demographic characteristics, habits, data about diabetes follow-up, treatments and results of BDI were analyzed. The patients were evaluated in terms of cardiovascular, neurological, and ophthalmologic complications. The control group comprised healthy volunteers without any additional diseases. Results: A total of 281 patients participated in this study and the depression rate was 66.5%. There were 156 females (55.5%) and 125 males (44.5%). Among them, 60.3% of females and 74.4% of males had depression. The mean blood glucose and HbA1c levels were 151 mg/dl (68-475) and 8 mg/dL (4-14), respectively. Based on BDI, 68% of T2DM patients (n=83) and 50% of T1DM patients (n=11) had depression (P=0.087). Depression rates were 66.7% (n=9) between the ages of 20 and 34 years (P=0.035), 50% (n=36) between the ages of 35 and 49 years, 27.5% (n=138) between the ages of 50 and 64 years, and 32.7% (n=98) over the age of 65 years. The control group (n=50) included 32 females (64%) and the depression rate was 35% (n=17). Conclusion: Every stage of diagnosis, treatment and follow up of diabetes causes physiological stress in patients, which reflects in their lives. We must consider that depression, a treatable disease, affects the management and treatment of diabetes.


Download data is not yet available.


Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018 Apr 1;138:271–81.

Depression and Other Common Mental Disorders: Global Health Estimates. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO.

Meurs M, Roest AM, Wolffenbuttel BHR, Stolk RP, Jonge P De, Rosmalen JGM. Association of Depressive and Anxiety Disorders With Diagnosed Versus Undiagnosed Diabetes : An Epidemiological Study of 90, 686 Participants. Psychosom Med. 2016;78(2):233–41.

Goldney RD, Phillips PJ, Fisher LJ, Wilson DH. Diabetes, Depression, and Quality of Life. Diabetes Care [Internet]. 2004 May 1;27(5):1066 LP – 1070.

Buzlu S. Diyabetin Psikososyal Boyutu. In: S. E, editor. Diyabet Hemşireliği Temel Bilgiler. 2002. p. 195–203.

Özkan S. Psikiyatrik Tıp: Konsultasyon Liyezon Psikiyatrisi. 1. Ed. İstanbul: Roche Publishing; 1993. 93–99 p.

Akbay Pırıldar Ş. Dahiliye ve Psikiyatri, Diyabette Depresyon ve Anksiyete Bozuklukları. 1. Edition. İstanbul: Okuyan Us Publishing; 2003. 7–44 p.

Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-71

Roy T, Lloyd CE. Epidemiology of depression and diabetes: a systematic review. J Affect Disord. 2012 Oct;142 Suppl:S8-21. doi: 10.1016/S0165-0327(12)70004-6. PMID: 23062861.

Hermanns N, Kulzer B, Krichbaum M, Kubiak T, Haak T. Affective and anxiety disorders in a German sample of diabetic patients: prevalence, comorbidity and risk factors. Diabet Med [Internet]. 2005 Mar 1;22(3):293–300.

Rajput R, Gehlawat P, Gehlan D, Gupta R, Rajput M. Prevalence and predictors of depression and anxiety in patients of diabetes mellitus in a tertiary care center. Indian J Endocrinol Metab. 2016;20(6):746–51.

Noh JH, Park JK, Lee HJ, Kwon SK, Lee SH, Park JH, et al. Depressive symptoms of type 2 diabetics treated with insulin compared to diabetics taking oral anti-diabetic drugs : A Korean study. 2005;69:243–8.

Işık NA, Buzlu S. Compared to Depressive Symptoms of Type 2 Diabetic Patients Who were Treated with Oral Anti-Diabetic Drugs and Insulin. Gazi Med J. 2016;27(4):189–92.

Alghamdi J, Matou-Nasri S, Alghamdi F, Alghamdi S, Alfadhel M, Padmanabhan S. Risk of Neuropsychiatric Adverse Effects of Lipid-Lowering Drugs : A Mendelian Randomization Study. Int J Neuropsychopharmacol. 2018;21(12):1067–75.

Agustini B, Mohebbi M, Woods RL, McNeil JJ, Nelson MR, Shah RC, et al. Association Between Statin Use and Depressive Symptoms in a Large Community-Dwelling Older Population Living in Australia and the USA: A Cross-Sectional Study. CNS Drugs [Internet]. 2019 Jul;33(7):685–94.

Köhler-Forsberg O, Gasse C, Petersen L, Nierenberg AA, Mors O, Østergaard SD. Statin treatment and the risk of depression. J Affect Disord [Internet]. 2019;246(December 2018):706–15.

Cham S, Koslik HJ, Golomb BA. Mood, Personality, and Behavior Changes During Treatment with Statins: A Case Series. Drug Saf - case reports [Internet]. 2016 Dec;3(1):1.

Musselman DL, Betan E, Larsen H, Phillips LS. Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol Psychiatry [Internet]. 2003 Aug 1;54(3):317–29.

Raval A, Dhanaraj E, Bhansali A, Grover S, Tiwari P. Prevalence & determinants of depression in type 2 diabetes patients in a tertiary care centre. Indian J Med Res. 2014;132(2):195–200.

Reddy P, Philpot B, Ford D, Dunbar JA. Identification of depression in diabetes: the efficacy of PHQ-9 and HADS-D. Br J Gen Pract [Internet]. 2010 Jun;60(575):e239–45.

Nichols GA, Brown JB. Unadjusted and Adjusted Prevalence of Diagnosed Depression in Type 2 Diabetes. Diabetes Care [Internet]. 2003 Mar 1;26(3):744 LP – 749.

Asghar S, Hussain A, Ali SMK, Khan AKA, Magnusson A. Prevalence of depression and diabetes: a population-based study from rural Bangladesh. Diabet Med [Internet]. 2007 Aug 1;24(8):872–7.

Li C, Ford ES, Strine TW, Mokdad AH. Prevalence of depression among US adults with diabetes: findings from the 2006 behavioral risk factor surveillance system. Diabetes Care. 2008;31(1):105–7.

Nouwen A, Nefs G, Caramlau I, Connock M, Winkley K, Lloyd CE, et al. Prevalence of depression in individuals with impaired glucose metabolism or undiagnosed diabetes: a systematic review and meta-analysis of the European Depression in Diabetes (EDID) Research Consortium. Diabetes Care [Internet]. 2011 Mar;34(3):752–62.

El Mahalli AA. Prevalence and Predictors of Depression among Type 2 Diabetes Mellitus Outpatients in Eastern Province, Saudi Arabia. Int J Health Sci (Qassim) [Internet]. 2015 Apr;9(2):119–26.

Öyekçin D. Bir devlet hastanesi psikiyatri polikliniğine bir yıl içinde başvuran olguların sosyodemografik özellikleri ve psikiyatrik tanı dağılımı. Anadolu Psikiyatr Derg. 2008;9(1):39–43.

Johnson B, Eiser C, Young V, Brierley S, Heller S. Prevalence of depression among young people with Type 1 diabetes: a systematic review. Diabet Med [Internet]. 2013 Feb 1;30(2):199–208.

Atasoy V, Anaforoğlu İ, Algün E, Kutanis R. Depression, Anxiety and Quality of Life Among Adult Turkish Patients with Type 1 Diabetes Mellitus. Turkish J Endocrinol Metab. 2013;28–32.






Research Article

How to Cite

Işık AC, Akın S. Depression prevalence among diabetic patients and comparison of demographics and complications. J Surg Med [Internet]. 2021 Feb. 1 [cited 2022 Jun. 25];5(2):179-82. Available from: